• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cross-neutralizing Anti-hemagglutinin Antibodies Isolated from Patients Infected with Avian Influenza A (H5N1) Virus

tetano

Editor, Senior Moderator
Biomed Environ Sci. 2020 Feb 20;33(2):103-113. doi: 10.3967/bes2020.014. [h=1]Cross-neutralizing Anti-hemagglutinin Antibodies Isolated from Patients Infected with Avian Influenza A (H5N1) Virus.[/h]
Sun Y[SUP]1[/SUP], Cao Y[SUP]2[/SUP], Li Z[SUP]1[/SUP], Bai T[SUP]1[/SUP], Zhang H[SUP]3[/SUP], Hu SX[SUP]3[/SUP], Li FC[SUP]3[/SUP], Zhao X[SUP]1[/SUP], Chen YK[SUP]4[/SUP], Lu J[SUP]1[/SUP], Liu LQ[SUP]1[/SUP], Wang DY[SUP]1[/SUP], Shu YL[SUP]4[/SUP], Zhou JF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Objective:[/h] To recover broad-neutralizing monoclonal antibodies (BnAbs) from avian influenza A (H5N1) virus infection cases and investigate their genetic and functional features.
[h=4]Methods:[/h] We screened the Abs repertoires of expanded B cells circulating in the peripheral blood of H5N1 patients. The genetic basis, biological functions, and epitopes of the obtained BnAbs were assessed and modeled.
[h=4]Results:[/h] Two BnAbs, 2-12D5, and 3-37G7.1, were respectively obtained from two human H5N1 cases on days 12 and 21 after disease onset. Both Abs demonstrated cross-neutralizing and Ab-dependent cellular cytotoxicity (ADCC) activity. Albeit derived from distinct Ab lineages, i.e., V [SUB]H[/SUB]1-69-D2-15-J [SUB]H[/SUB]4 (2-12D5) and V [SUB]H[/SUB]1-2-D3-9-J [SUB]H[/SUB]5 (3-32G7.1), the BnAbs were directed toward CR6261-like epitopes in the HA stem, and HA [SUB]2[/SUB] I45 in the hydrophobic pocket was the critical residue for their binding. Signature motifs for binding with the HA stem, namely, IFY in V [SUB]H[/SUB]1-69-encoded Abs and LXYFXW in D3-9-encoded Abs, were also observed in 2-12D5 and 3-32G7.1, respectively.
[h=4]Conclusions:[/h] Cross-reactive B cells of different germline origins could be activated and re-circulated by avian influenza virus. The HA stem epitopes targeted by the BnAbs, and the two Ab-encoding genes usage implied the VH1-69 and D3-9 are the ideal candidates triggered by influenza virus for vaccine development.
Copyright ? 2020 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.


[h=4]KEYWORDS:[/h] Antibody; Avian influenza A (H5N1) virus; Cross-neutralizing; D3-9; VH1-69

PMID: 32131957 DOI: 10.3967/bes2020.014
 
Back
Top Bottom